Ministers accused of overreacting to the Omicron variant will feel vindicated by the comments of Moderna chief executive Stéphane Bancel. In an interview with the FT, Bancel said he expects his company’s vaccine to suffer a ‘material drop’ in efficacy against Omicron – on the grounds that the new variant has 32 mutations to its spike protein.